Глензоцимаб

Rec. INN (наименование, зарегистрированное ВОЗ)

DB16175

2101829-58-5

immunoglobulin Fab G1-kappa, anti-[Homo sapiens GP6 (glycoprotein VI platelet, glycoprotein VI (platelet), GPVI, platelet glycoprotein VI)], humanized monoclonal antibody;
gamma1 heavy chain VH-CH1 humanized (1-227) [VH (Homo sapiens IGHV1-46*01 (92.9%) -(IGHD) -IGHJ4*01 (93.3%)) [8.8.13] (1-120) -Homo sapiens IGHG1*01, G1m17 (CH1 K120 (217) (121- 218), hinge 1-9 (219-227)) (121-227)], (223-214')-disulfide with kappa light chain humanized (1'-219') [V-KAPPA (Homo sapiens IGKV1-33*01 (80.0%) -IGKJ1*01 (100%)) [11.3.9] (1'-111') -1-mer (112') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (158), V101 (196) (113'-219')]

Поделиться этой страницей